Advertisement

Reproductive-Age Women's Experience of Accessing Treatment for Opioid Use Disorder: “We Don't Do That Here”

      Abstract

      Purpose

      For reproductive-age women, medications for opioid use disorder (OUD) decrease risk of overdose death and improve outcomes but are underutilized. Our objective was to provide a qualitative description of reproductive-age women's experiences of seeking an appointment for medications for OUD.

      Methods

      Trained female callers placed telephone calls to a representative sample of publicly listed opioid treatment clinics and buprenorphine providers in Florida, Kentucky, Massachusetts, Michigan, Missouri, North Carolina, Tennessee, Virginia, Washington, and West Virginia to obtain appointments to receive medication for OUD. Callers were randomly assigned to be pregnant or non-pregnant and have private or Medicaid-based insurance to assess differences in the experiences of access by these characteristics. The callers placed 28,651 uniquely randomized calls, 10,117 to buprenorphine-waivered prescribers and 754 to opioid treatment programs. Open-ended, qualitative data were obtained from the callers about the access experiences and were analyzed using a qualitative, iterative inductive-deductive approach. From all 28,651 total calls, there were 17,970 unique free-text comments to the question “Please give an objective play-by-play of the description of what happened in this conversation.”

      Findings

      Analysis demonstrated a common path to obtaining an appointment. Callers frequently experienced long hold times, multiple transfers, and difficult interactions. Clinic receptionists were often mentioned as facilitating or obstructing access. Pregnant callers and those with Medicaid noted more barriers. Obtaining an appointment was commonly difficult even for these persistent, trained callers.

      Conclusions

      Interventions are needed to improve the experiences of reproductive-age women as they enter care for OUD, especially for pregnant women and those with Medicaid coverage.
      To read this article in full you will need to make a payment
      Subscribe to Women's Health Issues
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • American College of Obstetricians and Gynecologists Committee on Obstetric Practice
        Committee Opinion No. 711: Opioid use and opioid use disorder in pregnancy.
        Obstetrics & Gynecology. 2017; 130: e81-e94
        • Andersen R.M.
        • McCutcheon A.
        • Aday L.A.
        • Chiu G.Y.
        • Bell R.
        Exploring dimensions of access to medical care.
        Health Services Research. 1983; 18: 49-74
        • Atkins D.N.
        • Durrance C.P.
        State policies that treat prenatal substance use as child abuse or neglect fail to achieve their intended goals: Study examines the effect of state policies that treat prenatal substance use as child abuse or neglect on the incidence of neonatal abstinence syndrome and other factors.
        Health Affairs. 2020; 39: 756-763
        • Azungah T.
        Qualitative research: deductive and inductive approaches to data analysis.
        Qualitative Research Journal. 2018;
        • Bisgaier J.
        • Rhodes K.V.
        Auditing access to specialty care for children with public insurance.
        New England Journal of Medicine. 2011; 364: 2324-2333
        • Brown J.D.
        • Goodin A.J.
        • Talbert J.C.
        Rural and Appalachian disparities in neonatal abstinence syndrome incidence and access to opioid abuse treatment.
        The Journal of Rural Health. 2018; 34: 6-13
        • Centers for Disease Control and Prevention
        Provisional drug overdose death counts. centers for disease control and prevention.
        (Available:)
        https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm
        Date: 2018
        Date accessed: June 24, 2020
        • Davis M.A.
        • Lin L.A.
        • Liu H.
        • Sites B.D.
        Prescription opioid use among adults with mental health disorders in the United States.
        The Journal of the American Board of Family Medicine. 2017; 30: 407-417
        • Daw J.R.
        • Kolenic G.E.
        • Dalton V.K.
        • Zivin K.
        • Winkelman T.
        • Kozhimannil K.B.
        • Admon L.K.
        Racial and ethnic disparities in perinatal insurance coverage.
        Obstetrics and Gynecology. 2020; 135: 917
        • Dick A.W.
        • Pacula R.L.
        • Gordon A.J.
        • Sorbero M.
        • Burns R.M.
        • Leslie D.
        • Stein B.D.
        Growth in buprenorphine waivers for physicians increased potential access to opioid agonist treatment, 2002–11.
        Health Affairs. 2015; 34: 1028-1034
        • Dube S.R.
        • Felitti V.J.
        • Dong M.
        • Chapman D.P.
        • Giles W.H.
        • Anda R.F.
        Childhood abuse, neglect, and household dysfunction and the risk of illicit drug use: The adverse childhood experiences study.
        Pediatrics. 2003; 111: 564-572
        • Feder K.A.
        • Mojtabai R.
        • Musci R.J.
        • Letourneau E.J.
        US adults with opioid use disorder living with children: Treatment use and barriers to care.
        Journal of Substance Abuse Treatment. 2018; 93: 31-37
        • Fereday J.
        • Muir-Cochrane E.
        Demonstrating rigor using thematic analysis: A hybrid approach of inductive and deductive coding and theme development.
        International Journal of Qualitative Methods. 2006; 5: 80-92
        • Goodman D.J.
        • Saunders E.C.
        • Wolff K.B.
        In their own words: a qualitative study of factors promoting resilience and recovery among postpartum women with opioid use disorders.
        BMC Pregnancy and Childbirth. 2020; 20: 1-10
        • Hardeman R.R.
        • Karbeah J.M.
        • Kozhimannil K.B.
        Applying a critical race lens to relationship-centered care in pregnancy and childbirth: An antidote to structural racism birth.
        Birth. 2019; 47: 3-7
        • Heuston J.
        • Groves P.
        • Nawad J.A.
        • Albery I.
        • Gossop M.
        • Strang J.
        Caught in the middle: receptionists and their dealings with substance misusing patients.
        Journal of Substance Use. 2001; 6: 151-157
        • Kaiser Family Foundation
        Current Status of State Medicaid Expansion Decisions.
        (Available:)
        • Kochanek K.D.
        • Murphy S.L.
        • Xu J.
        • Arias E.
        Deaths : Final data for 2017 Hyattsville, MD.
        (Available:)
        https://stacks.cdc.gov/view/cdc/79486
        Date: 2019
        Date accessed: August 7, 2020
        • Maeda A.
        • Bateman B.T.
        • Clancy C.R.
        • Creanga A.A.
        • Leffert L.R.
        Opioid abuse and dependence during pregnancytemporal trends and obstetrical outcomes.
        Anesthesiology: The Journal of the American Society of Anesthesiologists. 2014; 121: 1158-1165
        • Martin J.A.
        • Hamilton B.E.
        • Osterman M.J.
        • Driscoll A.K.
        Births: Final Data for 2018.
        National Vital Statistics Reports. 2019; 68
        • National Academies of Sciences, Engineering, & Medicine
        Medications for opioid use disorder save lives.
        National Academies Press, Washington DC2019 (Accessed: June 23, 2020.)
        • Patrick S.W.
        • Buntin M.B.
        • Martin P.R.
        • Scott T.A.
        • Dupont W.
        • Richards M.
        • Cooper W.O.
        Barriers to Accessing Treatment for Pregnant Women with Opioid Use Disorder in Appalachian States.
        Substance Abuse. 2018; (Accessed: January 1, 2020.): 1-18
        • Patrick S.W.
        • Davis M.M.
        • Lehmann C.
        • Cooper W.O.
        Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012.
        Journal of Perinatology. 2015; 35: 650-655
        • Patrick S.W.
        • Faherty L.J.
        • Dick A.W.
        • Scott T.A.
        • Dudley J.
        • Stein B.D.
        Association Among County-Level Economic Factors, Clinician Supply, Metropolitan or Rural Location, and Neonatal Abstinence Syndrome.
        JAMA. 2019; 321: 385-393
        • Patrick S.W.
        • Richards M.R.
        • Dupont W.D.
        • McNeer E.
        • Buntin M.B.
        • Martin P.R.
        • Leech A.A.
        Association of pregnancy and insurance status with treatment access for opioid use disorder.
        JAMA network open. 2020; 3: e2013456
        • Phillippi J.
        Women's perceptions of access to prenatal care in the United States: A literature review.
        Journal of Midwifery & Women's Health. 2009; 54: 219-225
        • Phillippi J.
        • Myers C.
        • Schorn M.
        Facilitators of prenatal care access in rural Appalachia.
        Women and Birth. 2014; 27: e28-e35
        • Phillippi J.C.
        • Holley S.L.
        • Payne K.
        • Schorn M.N.
        • Karp S.M.
        Facilitators of prenatal care in an exemplar urban clinic.
        Women and Birth. 2016; 29: 160-167
        • Phillippi J.C.
        • Roman M.W.
        The motivation-facilitation theory of prenatal care access.
        Journal of Midwifery & Women's Health. 2013; 58: 509-515
        • Polsky D.
        • Richards M.
        • Basseyn S.
        • Wissoker D.
        • Kenney G.M.
        • Zuckerman S.
        • Rhodes K.V.
        Appointment availability after increases in Medicaid payments for primary care.
        New England Journal of Medicine. 2015; 372: 537-545
        • Price T.E.
        Secretary Price Announces HHS Strategy for Fighting Opioid Crisis: Atlanta, Georgia.
        (Available:)
        • Ricketts T.C.
        • Goldsmith L.J.
        Access in health services research: The battle of the frameworks.
        Nursing Outlook. 2005; 53: 274-280
        • Saloner B.
        • Cook B.L.
        Blacks and Hispanics are less likely than whites to complete addiction treatment, largely due to socioeconomic factors.
        Health Affairs. 2013; 32: 135-145
        • Sharp A.
        • Jones A.
        • Sherwood J.
        • Kutsa O.
        • Honermann B.
        • Millett G.
        Impact of Medicaid expansion on access to opioid analgesic medications and medication-assisted treatment.
        American Journal of Public Health. 2018; 108: 642-648
        • Stone R.
        Pregnant women and substance use: fear, stigma, and barriers to care.
        Health & Justice. 2015; 3: 2
        • Stringer K.L.
        • Baker E.H.
        Stigma as a barrier to substance abuse treatment among those with unmet need: an analysis of parenthood and marital status.
        Journal of Family Issues. 2018; 39: 3-27
        • Substance Abuse and Mental Health Services Administration
        Buprenorphine practitioner locator.
        (Available:) (Accessed: December 2018)
        • Substance Abuse and Mental Health Services Administration
        Opioid Treatment Program Directory.
        (Available:) (Accessed: December 2018)
        • Tipirneni R.
        • Rhodes K.V.
        • Hayward R.A.
        • Lichtenstein R.L.
        • Reamer E.N.
        • Davis M.M.
        Primary care appointment availability for new Medicaid patients increased after Medicaid expansion in Michigan.
        Health Affairs. 2015; 34: 1399-1406
        • Tong A.
        • Sainsbury P.
        • Craig J.
        Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups.
        International Journal for Quality in Health Care. 2007; 19: 349-357
        • Wilson N.
        Drug and opioid-involved overdose deaths—United States, 2017–2018.
        MMWR Morbidity and Mortality Weekly Report. 2020; 69

      Biography

      Julia C. Phillippi PhD, CNM, is an Assistant Professor at Vanderbilt University School of Nursing and a Certified Nurse-Midwife at Vanderbilt University Medical Center. Her research focuses on access to perinatal care.

      Biography

      Rebecca Schulte, BA, is a health research assistant. She is currently pursuing her MPH with a concentration in epidemiology. Her research interests include physical activity, nutrition, and chronic disease prevention and the impacts of social determinants on health.

      Biography

      Kemberlee Bonnet, MA, is a social scientist and the Vanderbilt University Qualitative Research Core coordinator. Her background is in social psychology, and she is experienced in community-based recruitment, focus group development and facilitation, conducting one-on-one and group interviews, and qualitative data analysis.

      Biography

      David G. Schlundt, PhD, is an Associate Professor of Psychology at Vanderbilt University and is the director of the Vanderbilt Qualitative Research Core. His research has focused broadly on health and behavior in diabetes, obesity, heart disease, and cancer.

      Biography

      William O. Cooper, MD, MPH, Cornelius Vanderbilt Professor of Pediatrics and Health Policy at Vanderbilt University School of Medicine, is a practicing pediatrician and conducts research on safety of prescription medications during pregnancy for pregnant women and their infants.

      Biography

      Peter R. Martin, MD, MSc, is Professor of Psychiatry and Behavioral Sciences and Pharmacology and an addiction psychiatrist at Vanderbilt University Medical Center. His research includes the molecular basis, diagnosis, and treatment of drug use disorders and substance-induced mental disorders.

      Biography

      Katy Backes Kozhimannil, PhD, MPA, is Professor at the University of Minnesota School of Public Health and Director of the University's Rural Health Research Center. Her research contributes evidence for clinical and policy strategies to advance racial, gender, and geographic equity.

      Biography

      Stephen W. Patrick, MD, MPH, MS, is the Director of the Vanderbilt Center for Child Health Policy, Associate Professor of Pediatrics and Health Policy and a neonatologist at Vanderbilt University Medical Center. His research focuses on improving outcomes for pregnant women and infants affected by the opioid crisis.